ORIENT-32 trial: sintilimab + bevacizumab biosimilar as a promising combination therapy in advanced hepatocellular carcinoma
@article{DMR7739, author = {Brandon Swed and Omar Gandarilla and Gagandeep Brar}, title = {ORIENT-32 trial: sintilimab + bevacizumab biosimilar as a promising combination therapy in advanced hepatocellular carcinoma}, journal = {Digestive Medicine Research}, volume = {4}, number = {0}, year = {2021}, keywords = {}, abstract = {}, issn = {2617-1627}, url = {https://dmr.amegroups.org/article/view/7739} }